Delivery Order SPE2DX15D3014-SPE2DX24FXDCE
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Estrogen-Methyltestosterone tablets. The $1,201.82 firm fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,316.14, is for the delivery of ESTROGEN-METHYLTESTOS F.S. TAB 100S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has a completion date of September 10, 2021. The contract is not designated with a set-aside requirement, indicating open...
- This federal contract award is for the delivery of Estrogen-Methyltestos H.S. Tablets in quantities of 100 to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,053.00, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a firm fixed-price pricing type and an ultimate completion date of March 28, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery...
- This federal contract award is a delivery order valued at $2,946.08 that was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of Tri-Estarylla tablets, a pharmaceutical product, to support military healthcare programs. The contract has a firm fixed price pricing type and a period of performance through March 21, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Estradiol-Noreth 0.5-0.1 mg tablets to the Defense Logistics Agency (DLA). The $1,347.32 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This order is a part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC enables Cencora, Inc. to supply a...
- The federal contract award is between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,143.74, is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and various medical devices and equipment. This contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, identified as SPE2DX22D0019|SPE2D824FJF09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,271.55 firm fixed-price delivery order is for the provision of pharmaceutical products and medical supplies to support federal healthcare programs, particularly military and veterans' health services. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora,...
- This federal contract award, with ID SPE2DX22D0029|SPE2D824F12BZ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,789.44 firm fixed-price delivery order is for the supply of various pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and other critical care items. The contract is part of a larger...
- This federal contract award, valued at $1,987.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare...
- This federal contract award, with ID SPE2DX16D4014|SPE2DX24FJ237, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $10,538.79, is for the delivery of pharmaceutical products and medical supplies, including specialty medications, generic drugs, branded pharmaceuticals, medical devices, syringes, vials, and more, to support military treatment facilities, veterans'...
- SPE2DX15D3014Indefinite Delivery Contract
- SPE2DX15D3014-SPE2DX24FXDCEDelivery Order
This federal contract award, with ID SPE2DX15D3014|SPE2DX24FXDCE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,011.46 Firm Fixed Price contract is for the delivery of ESTROGEN-METHYLTESTOS H.S. TAB 100S, a pharmaceutical product, to support military and federal healthcare programs. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. It is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal agencies. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/6/24 |